Nick Norwitz weighs the cancer risks of peptides like BPC-157 and CJC-1295, which could feed tumors, against potential benefits like immune enhancement and reduced inflammation. He stresses the gaps in current knowledge and warns against both fear-mongering and false promises.
Chapters
Do peptides cause cancer? I get that question almost every week now, and the honest answer is more interesting than yes or no, because the same peptides might do both. Here's the scary half first. Some peptides, like BPC-157, tell your body to grow new blood vessels. That's called angiogenesis, and blood vessels are how organs, but also baby tumors, get fed. Other peptides, like CJC-1295 or Sermorelin, crank up the growth hormone pathways, and if a cancer is already sitting there quietly, those signals could, in theory, help a cancer grow. So, the fear isn't made up, it is speculation, but it's not nonsense. But we can flip it, because there could be benefits. Consider the humble thymus. It sits right beneath your breastbone and is central to the immune system and what's called immunosurveillance. Your immune system going down hunting down early cancer cells and zapping them away. And adults with healthy thymuses tend to have lower cancer rates, and that seems to be tied to thymic function, which can be rejuvenated through those same growth hormone pathways, at least in early human studies. So the exact peptide that in theory could feed your tumor through growth hormone might also help your body kill it first. But we can go further. Consider inflammation and mitochondrial dysfunction, both may feed early cancer formation, and peptides can heal those underlying pathologies too. The truth is there's a ton we don't know. Potential risks, potential benefits stacked on both sides. And I don't think the answer is to fearmonger or sell false promises. It's just to be honest about where the science actually stands and then pursue better answers. So my call to action for you is not to take or not to take, but to continue to learn so whatever decision you ultimately make isn't done blindly and you can keep asking questions like